Your tip
RadarOnlineRadarOnline
or
Sign in with lockrMail
BREAKING NEWS

U.S. Mpox Red Alert: Biden-Harris Administration Admit They Are 'Closely Monitoring' Deadly Disease As It Spreads Outside Africa

Composite photo of Joe Biden.
Source: MEGA;UNSPLASH

The Biden-Harris administration is closely monitoring the spread of clade I mpox to prepare for potential outbreak.

Aug. 23 2024, Published 5:00 p.m. ET

Link to FacebookShare to XShare to FlipboardShare to Email

The Biden-Harris Administration admitted they're closely monitoring increasing cases of the highly infectious mpox disease.

In the wake of the pandemic, there are growing concerns about the rapid spread of mpox, formerly known as monkeypox, outside of Africa.

Following the surge of cases in the Democratic Republic of the Congo, the U.S. federal government established an "incident response structure" across agencies as a proactive measure for "domestic preparedness", RadarOnline.com can reveal.

Article continues below advertisement
biden harris administration admit closely monitoring mpox infections unsplash
Source: UNSPLASH

The WHO reinstated the status of clade I mpox as a Public Health Emergency of International concern.

Article continues below advertisement

The World Health Organization (WHO) reinstated the status of clade I mpox as a Public Health Emergency of International Concern on August 21 as the virus spread outside of the DRC.

Sweden announced its first recorded case of clade I mpox on August 22.

Article continues below advertisement

Dr. Pamela Rendi-Wagner, director of the European Centre for Disease Prevention and Control, announced the agency raised the mpox risk level from "very low" to "low", while highlighting the increasing need for preparedness.

Rendi-Wagner said: "Due to the close links between Europe and Africa we must be prepared for more imported clade I cases."

Though the CDC confirmed there were no reported cases of clade I mpox in the U.S., officials warned monitoring the spread of cases from Africa should be taken seriously.

Article continues below advertisement
biden harris administration admit closely monitoring mpox infections
Source: By: MEGA

Sweden recorded its first clade I mpox case this week.

Article continues below advertisement

UCLA epidemiologist Anne Rimoin said: "I think we have to be very, very cautious about saying that this is more dangerous."

"The data on the severity, associated mortality — all of that is scant. There are a lot of questions about whether or not the perceived severity might have more to do with the population that it’s spreading in, their immune system, the route of transmission, the infectious dose."

Article continues below advertisement
biden harris administration admit closely monitoring mpox infections
Source: By: MEGA

The mpox variant is believed to be more severe than clade II, which broke out in 2022.

MORE ON:
POLITICS

DAILY. BREAKING. CELEBRITY NEWS. ALL FREE.

Article continues below advertisement

Because clade I is considered to be a more serious and transmissible variant of clade II mpox, which drove the global outbreak in 2022. Therefore immunocompromised individuals, particularly those with advanced, untreated HIV are said to be at a greater risk of severe illness, hospitalization and death, according to NBC News.

Since 2022, the U.S. has continued to witness a low spread of clad II cases.

Article continues below advertisement

Harvard Medical School virologist Dr. Dan Barouch further warned that the U.S. would likely see reported cases of clade I mpox.

Barouch said: "The absolute risk in the U.S. is currently low. Although we need to remain vigilant."

CDC officials first warned of potential clade I cases in December. The agency updated their advisory on August 7.

Article continues below advertisement
biden harris administration admit closely monitoring mpox infections
Source: By: MEGA

Though the clade I risk in the U.S. is said to be low, experts warn the country needs to be 'vigilant'.

Article continues below advertisement

A recent study revealed promising results from the TPOXX antiviral in a DRC clinical trial. Though the vaccine did not reduce clade I symptoms, only 1.7 percent of patients died compared to the typical DRC death rate of 3.6 percent or higher.

Dr. Jennifer McQuiston, epidemiologist and lead for the CDC mpox clade I response, believed the study showed promise for patients receiving higher quality health care in the U.S. Nevertheless, the agency remains vigilant about early detection and monitoring the spread of cases globally.

McQuiston added: "We are more worried about clade I than we are about clade II."

Article continues below advertisement

Have a tip? Send it to us! Email RadarOnline.com at tips@radaronline.com.

More From Radar Online

    Opt-out of personalized ads

    © Copyright 2024 RADAR ONLINE™️. A DIVISION OF MYSTIFY ENTERTAINMENT NETWORK INC. RADAR ONLINE is a registered trademark. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service, Privacy Policy and Cookies Policy. People may receive compensation for some links to products and services. Offers may be subject to change without notice.